Skip to content
The Kids Research Institute Australia logo
Donate

No results yet

Search

Showing results for "1"

News & Events

Cholesterol and blood pressure drugs help teens with diabetes

The study involved screening young people to learn more about the development of long-term kidney, eye and cardiovascular complications in adolescents with T1D.

Research

Immunogenicity and Safety of a Quadrivalent Meningococcal ACWY-tetanus Toxoid Conjugate Vaccine 6 Years After MenC Priming as Toddlers

One dose of MenACWY-TT boosts protection against MenC in primed children, is safe and extends protection against MenA, MenW and MenY

News & Events

Healthcare Transition Support

HEALTHCARE TRANSITION STUDY Co-designing transition support: Phase 1 For young people with type 1 diabetes (T1D), growing up means moving from child

Research

Prevalence of celiac disease in 52,721 youth with type 1diabetes: International comparison across three continents

Tim Jones MBBS DCH FRACP MD Co-head, Diabetes and Obesity Research Co-head, Diabetes and Obesity Research Areas of research expertise: Diabetes

News & Events

Teaching Kitchens

the Teaching Kitchens program will start again on Thursday March 9 from 5-7pm,  running for four weeks (every thursday evening).

News & Events

Changes to the continuous glucose monitoring initiative from 1st March, 2022.

The Dexcom G6 CGM system will be available through the NDSS to all our patients with Type 1 diabetes.

News & Events

Congratulations Vinutha

Congratulations to Dr Vinutha Shetty who has been awarded a Type 1 Diabetes Clinical Research Network’s Mentored Clinician Researcher Fellowship Award for 2017.

News & Events

Latitudinal gradient in childhood diabetes

New research from Perth's The Kids Research Institute Australia has shown the local relevance of a worldwide pattern of increased risk of childhood type 1 diabetes.

Research

The Cost of Control: Cost-effectiveness Analysis of Hybrid Closed-Loop Therapy in Youth

Hybrid closed-loop (HCL) therapy is an efficacious management strategy for young people with type 1 diabetes. However, high costs prevent equitable access. We thus sought to evaluate the cost-effectiveness of HCL therapy compared with current care among young people with type 1 diabetes in Australia.